Prophylaxis of cytomegalovirus disease with intravenous ganciclovir in renal transplantation

Transplantation Proceedings

Volumn 31, Issue 6, 1999, Pages 2337-2338

  Sancho, A ^a   Gorriz J L ^a   Crespo, J F ^a   Avila, A ^a   Alcaraz, M J ^b   Garcia Ramos J L ^a   Pallardo L M ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; MYCOPHENOLIC ACID; OKT 3; TACROLIMUS;

ACUTE KIDNEY TUBULE NECROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROPHYLAXIS;

ADULT; AGED; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GANCICLOVIR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 0345062242     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00367-X     Document Type: Conference Paper

References (4)

1. Ho M. Transplant Proc. 26:(suppl 1):1994;7.
2. Goral S., Helderman J.H. Transplant Proc. 26:(suppl 1):1994;5.
3. Snydman D.R. Transplant Proc. 26:(suppl 1):1994;20.
4. Ram Peddi V., Hariharan S., Schroeder T.J., et al. Nephron. 76:1997;49.